Trial Profile
An open-label, randomized, clinical study assessing the safety and immunogenicity of JVC-001 in Japanese healthy children
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs JVC 001 (Primary)
- Indications Measles; Mumps; Rubella
- Focus Adverse reactions; Therapeutic Use
- Sponsors Japan Vaccine
- 08 Nov 2018 Status changed from recruiting to completed.
- 22 Jan 2018 New trial record